Jade Biosciences, Inc. (JBIO) Discusses JADE301 Program Profile and Preclinical Data in Dermatomyositis - Slideshow

🇺🇸 Seeking Alpha (US) —

AI Summary

Jade Biosciences presented the profile and preclinical data for its JADE301 program in dermatomyositis in an investor presentation. The source description provides no additional details about the findings or the program’s development status.

Markets Health Jade Biosciences JADE301 dermatomyositis preclinical data biotechnology drug development

Read original source →